Annora Pharma Private Limited - Company Profile

It is a pharma private limited company based in Village, Gummadidala Mandal, Telangana, India, established in 2015.
2015 Village, Gummadidala Mandal, Telangana, India Active
Last Updated:
Access Report
About Annora Pharma Private Limited

Annora Pharma Private Limited, a active private limited company, was established on 26 November 2015 in Village, Gummadidala Mandal, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TG2015PTC101939. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹316.00 Cr and a paid-up capital of ₹271.00 Cr.

It upholds a compliant status. Its leadership includes Kiran Kumar Manikwar (Company Secretary), Govindaraju Bhavani (Director), Mahesh Ramappa Kamalamma Hassan (Director). Past directors included Govindaraju Bhavani, Chandra Sekhar Tumuluru, Chittajallu Gopalakrishna. It holds ₹610.82 Cr open charges and no settled loans. Its latest AGM occurred on 05 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sy.No.261, Plot No.5,7,8,9,13 And 14, Village, Gummadidala Mandal, Telangana, 502313.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TG2015PTC101939

  • Registration Number

    101939

  • Incorporation Date

    26 November 2015

  • Authorized Capital

    ₹316.00 Cr

  • Paid-Up Capital

    ₹271.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 316.00 Cr
  • Paid Up Capital ₹ 271.00 Cr
  • Company Age 10 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 610.82 Cr
  • Revenue Growth **** 31.62%
  • Profit Growth **** 221.74%
  • Ebitda **** 73.59%
  • Net Worth 31.20%
  • Total Assets **** 18.85%
Company report

Annora Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Annora Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Annora Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Kiran Kumar Manikwar Company Secretary 24 Feb 2025 Current
Govindaraju Bhavani Director 30 Jun 2022 Current
Mahesh Ramappa Kamalamma Hassan Director 30 Mar 2018 Current
Bhaskarreddy Pabbatireddy Director 05 Mar 2020 Current
Palleswara Rao Palapatla Govada Director 26 Nov 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 22 Sep 2022 Past
Pramod Abcsdd Director 05 Sep 2025 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 30 Aug 2018 Past
Pramod Abcsdd Additional Director 03 Sep 2020 Past
Pramod Abcsdd Cfo - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Annora Pharma.

Annora Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.62% increase. The company also saw a substantial improvement in profitability, with a 221.74% increase in profit. The company's net worth Soared by an impressive increase of 31.2%.

Annora Pharma revenue growth over time
Annora Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 31.62%
*******
*******
*******
*******
Revenue from Operations
*******
 28.10%
*******
*******
*******
*******
Total Assets
*******
 18.85%
*******
*******
*******
*******
Profit or Loss
*******
 221.74%
*******
*******
*******
*******
Net Worth
*******
 31.20%
*******
*******
*******
*******
EBITDA
*******
 73.59%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Annora Pharma?

In 2023, Annora Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹6,108,171,289.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 450.06 Cr
  • Axis Bank Limited : 160.00 Cr
  • Hdfc Bank Limited : 0.76 Cr
Latest Charge Details
Date Lender Amount Status
30 Dec 2024 Others ₹214.50 Cr Open
20 Dec 2023 Axis Bank Limited ₹160.00 Cr Open
22 Mar 2023 Others ₹0.90 M Open
10 Sep 2022 Others ₹0.90 M Open
30 Apr 2022 Others ₹3.80 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Annora Pharma?

Unlock and access historical data on people associated with Annora Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Annora Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Annora Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Annora Pharma
Recent Activity within the Organization
  • Charges

    The activity A charge with Axis Bank Limited of Rs. 160.00 Cr registered on 20 Dec 2023 with Charge ID 100844888 was modified on 25 Nov 2025. was completed.

  • Annual General Meeting

    Annora Pharma Private Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Annora Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Director Appointment

    The activity Kiran Kumar Manikwar was appointed as a Company Secretary was appointed as a Company Secretary on 24 Feb 2025 & has been associated with this company since 1 year 3 months . was completed.

  • Charges

    The activity A charge with Others amounted to Rs. 214.50 Cr with Charge ID 101022522 was registered on 30 Dec 2024. was completed.

  • Director Appointment

    The activity Bandi Venkatarami Reddy was appointed as a Cfo was appointed as a Cfo on 13 Dec 2024 & has been associated with this company since 1 year 5 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Annora Pharma Private Limited?

The CIN of Annora Pharma Private Limited is U24100TG2015PTC101939.

Where is Annora Pharma Private Limited headquartered?

Annora Pharma Private Limited is headquartered at Sy.No.261, Plot No.5,7,8,9,13 And 14, Village, Gummadidala Mandal, Telangana, 502313.

When was Annora Pharma Private Limited incorporated?

Annora Pharma Private Limited was incorporated on 26 November 2015.

Who are the current directors of Annora Pharma Private Limited?

The current directors of Annora Pharma Private Limited are

What is the primary industry of Annora Pharma Private Limited?

The primary industry of Annora Pharma Private Limited is Manufacturing.

Is Annora Pharma Private Limited a listed company?

Annora Pharma Private Limited is unlisted.

What is the capital structure of Annora Pharma Private Limited?

The authorized capital of Annora Pharma Private Limited is ₹316.00 Cr, and the paid-up capital is ₹271.00 Cr.

What is the compliance status of Annora Pharma Private Limited?

The compliance status of Annora Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available